JPRN-UMIN000008984尚未招募2 期
Protective effect of kidney by low dose of darbepoetin alfa in patients with chronic kidney disease - Protective effect of kidney by low dose of darbepoetin alfa in patients with chronic kidney disease
Chiba university hospital, Nephrology0 个研究点目标入组 40 人开始时间: 2012年9月30日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Excluded patients with hypertension uncontrolled, congestive heart failure, surgery with massive bleeding within 16 weeks, blood disorders and malignancies, with patients treated with Doosan Mepichiosutan Henin and anabolic hormone and testosterone within 16 weeks, drug allergy, collagen disease and vasculitis, and patients who received a blood transfusion within 16 weeks.
研究者
相似试验
已完成
不适用
PRevention of End stage kidney disease by Darbepoetin Alfa In CKD patients with non-diabeTic kidney disease.JPRN-UMIN000006616PREDICT steering committee440
已完成
不适用
The investigation of the renal protective effect of Carperitide(hANP:human atrial natriuretic peptide) during adult living donor renal transplantation, a single center experience.living donor renal transplantationJPRN-UMIN000014279Toho University School of Medicine, Department of Anesthesiology30
尚未招募
不适用
Study of renal function renal protective effect of cooling method in laparoscopic partial nephrectomyRenal cell cacinomaJPRN-UMIN000013867Kansai Medical University30
招募中
3 期
ycopene nephroprotective effect in patients receiving vancomyciIRCT20171030037093N37Esfahan University of Medical Sciences60
已完成
不适用
Comparative study of the renal toxicity of dosage regimen containing high and conventional doses of colistin with monitoring of novel biomarkers of acute kidney injuryIRCT2014090614693N5Faculty of Pharmacy, Shahid Beheshti university of medical sciences40